Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLEA: CSE-1034 vs Meropenem in cUTI
NCT03477422Phase 3Completed
- Sponsor
- Venus Remedies
- Start
- Jan 2014
- Primary completion
- May 2017
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ceftriaxone + sulbactam + edta in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Venus Remedies. Started Jan 2014; status: completed.
02
Drugs
ceftriaxone + sulbactam + edta
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT03477422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03477422.